CAVA vs TMO · P/E 77, rev $963.7M vs P/E 24, rev $44.56B
CAVA Group, Inc. (CAVA) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
CAVA Group, Inc. (CAVA) is a restaurants company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CAVA revenue for 2024-12-29 was $963.7M. Net income was $130.3M. Revenue was up 32.3% from 2023-12-31 to 2024-12-29. CAVA currently screens at market cap $10.65B and trailing P/E 76.7.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CAVA currently screens at market cap $10.65B and trailing P/E 76.7. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CAVA and TMO stock pages for the full models.
Not investment advice.